Overall, this work highlights the relevance of SIRT2, particularly in the context of HFD-induced metabolic dysfunction, where its deficiency leads to disruption of hepatic lipid homeostasis and the development of NAFLD. This evidence concerns the gene SIRT2 and metabolic dysfunction-associated steatotic liver disease.